vs
Axil Brands, Inc.（AXIL）与Cytosorbents Corp（CTSO）财务数据对比。点击上方公司名可切换其他公司
Cytosorbents Corp的季度营收约是Axil Brands, Inc.的1.1倍（$9.2M vs $8.1M），Axil Brands, Inc.净利率更高（8.7% vs -59.5%，领先68.2%），Axil Brands, Inc.同比增速更快（5.2% vs 0.9%），Axil Brands, Inc.自由现金流更多（$906.4K vs $-4.9M），过去两年Axil Brands, Inc.的营收复合增速更高（12.1% vs 1.3%）
Axil Brands是一家总部位于美国的专业消费电子企业，主营高端听力防护设备、音频增强装置及个性化音频配件，旗下产品涵盖定制耳塞、运动蓝牙耳机等，面向全球普通消费者及专业作业群体销售。
Cytosorbents是一家公开上市企业，总部位于美国新泽西州普林斯顿，专注于血液净化领域相关医疗产品的研发与商业化，核心产品应用于重症救治场景，帮助去除患者血液中的炎性介质等有害物质。
AXIL vs CTSO — 直观对比
营收规模更大
CTSO
是对方的1.1倍
$8.1M
营收增速更快
AXIL
高出4.3%
0.9%
净利率更高
AXIL
高出68.2%
-59.5%
自由现金流更多
AXIL
多$5.8M
$-4.9M
两年增速更快
AXIL
近两年复合增速
1.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.1M | $9.2M |
| 净利润 | $704.9K | $-5.5M |
| 毛利率 | 68.1% | 73.7% |
| 营业利润率 | 11.1% | -47.5% |
| 净利率 | 8.7% | -59.5% |
| 营收同比 | 5.2% | 0.9% |
| 净利润同比 | 11.2% | 27.4% |
| 每股收益（稀释后） | $0.09 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXILCTSO
| Q4 25 | $8.1M | $9.2M | ||
| Q3 25 | $6.9M | $9.5M | ||
| Q2 25 | $5.8M | $9.6M | ||
| Q1 25 | $6.9M | $8.7M | ||
| Q4 24 | $7.7M | $9.2M | ||
| Q3 24 | $5.9M | $8.6M | ||
| Q2 24 | $6.5M | $8.8M | ||
| Q1 24 | $6.5M | $9.0M |
净利润AXILCTSO
| Q4 25 | $704.9K | $-5.5M | ||
| Q3 25 | $334.3K | $-3.2M | ||
| Q2 25 | $-245.6K | $1.9M | ||
| Q1 25 | $576.7K | $-1.5M | ||
| Q4 24 | $633.7K | $-7.6M | ||
| Q3 24 | $-109.8K | $-2.8M | ||
| Q2 24 | $49.5K | $-4.3M | ||
| Q1 24 | $781.1K | $-6.1M |
毛利率AXILCTSO
| Q4 25 | 68.1% | 73.7% | ||
| Q3 25 | 67.6% | 70.3% | ||
| Q2 25 | 70.0% | 70.9% | ||
| Q1 25 | 71.7% | 71.1% | ||
| Q4 24 | 71.1% | 68.4% | ||
| Q3 24 | 71.0% | 61.0% | ||
| Q2 24 | 71.5% | 73.5% | ||
| Q1 24 | 71.5% | 76.5% |
营业利润率AXILCTSO
| Q4 25 | 11.1% | -47.5% | ||
| Q3 25 | 6.0% | -30.2% | ||
| Q2 25 | 0.8% | -37.6% | ||
| Q1 25 | 8.4% | -44.5% | ||
| Q4 24 | 8.7% | -37.1% | ||
| Q3 24 | -2.4% | -56.1% | ||
| Q2 24 | 2.6% | -40.4% | ||
| Q1 24 | -1.6% | -51.8% |
净利率AXILCTSO
| Q4 25 | 8.7% | -59.5% | ||
| Q3 25 | 4.9% | -33.4% | ||
| Q2 25 | -4.3% | 20.2% | ||
| Q1 25 | 8.3% | -16.9% | ||
| Q4 24 | 8.2% | -82.7% | ||
| Q3 24 | -1.9% | -32.1% | ||
| Q2 24 | 0.8% | -48.6% | ||
| Q1 24 | 12.1% | -67.7% |
每股收益（稀释后）AXILCTSO
| Q4 25 | $0.09 | $-0.09 | ||
| Q3 25 | $0.04 | $-0.05 | ||
| Q2 25 | $-0.03 | $0.03 | ||
| Q1 25 | $0.07 | $-0.02 | ||
| Q4 24 | $0.08 | $-0.14 | ||
| Q3 24 | $-0.02 | $-0.05 | ||
| Q2 24 | $0.11 | $-0.08 | ||
| Q1 24 | $0.04 | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.0M | $6.2M |
| 总债务越低越好 | $138.3K | — |
| 股东权益账面价值 | $11.1M | $5.9M |
| 总资产 | $16.2M | $44.2M |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势，按日历期对齐
现金及短期投资AXILCTSO
| Q4 25 | $5.0M | $6.2M | ||
| Q3 25 | $4.1M | $7.5M | ||
| Q2 25 | $4.8M | $10.2M | ||
| Q1 25 | $4.7M | $11.6M | ||
| Q4 24 | $5.2M | $3.3M | ||
| Q3 24 | $4.1M | $5.7M | ||
| Q2 24 | $3.3M | $8.5M | ||
| Q1 24 | $4.9M | $8.6M |
总债务AXILCTSO
| Q4 25 | $138.3K | — | ||
| Q3 25 | $139.2K | — | ||
| Q2 25 | $140.2K | — | ||
| Q1 25 | $141.0K | — | ||
| Q4 24 | $143.3K | — | ||
| Q3 24 | $144.3K | $13.8M | ||
| Q2 24 | $146.6K | $13.7M | ||
| Q1 24 | — | $4.4M |
股东权益AXILCTSO
| Q4 25 | $11.1M | $5.9M | ||
| Q3 25 | $10.2M | $9.0M | ||
| Q2 25 | $9.7M | $11.6M | ||
| Q1 25 | $9.7M | $14.5M | ||
| Q4 24 | $8.8M | $11.1M | ||
| Q3 24 | $7.9M | $13.4M | ||
| Q2 24 | $7.7M | $17.4M | ||
| Q1 24 | $8.8M | $19.6M |
总资产AXILCTSO
| Q4 25 | $16.2M | $44.2M | ||
| Q3 25 | $15.4M | $45.8M | ||
| Q2 25 | $12.9M | $48.0M | ||
| Q1 25 | $13.0M | $50.8M | ||
| Q4 24 | $13.7M | $47.4M | ||
| Q3 24 | $11.4M | $47.8M | ||
| Q2 24 | $11.0M | $53.4M | ||
| Q1 24 | $12.7M | $47.1M |
负债/权益比AXILCTSO
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | 0.02× | 1.03× | ||
| Q2 24 | 0.02× | 0.78× | ||
| Q1 24 | — | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $934.8K | $-4.8M |
| 自由现金流经营现金流 - 资本支出 | $906.4K | $-4.9M |
| 自由现金流率自由现金流/营收 | 11.1% | -53.4% |
| 资本支出强度资本支出/营收 | 0.3% | 1.2% |
| 现金转化率经营现金流/净利润 | 1.33× | — |
| 过去12个月自由现金流最近4个季度 | — | $-12.5M |
8季度趋势，按日历期对齐
经营现金流AXILCTSO
| Q4 25 | $934.8K | $-4.8M | ||
| Q3 25 | $-739.2K | $-2.6M | ||
| Q2 25 | $194.4K | $-1.5M | ||
| Q1 25 | $-169.9K | $-3.5M | ||
| Q4 24 | $1.0M | $-2.3M | ||
| Q3 24 | $897.3K | $-2.5M | ||
| Q2 24 | $-336.6K | $-4.8M | ||
| Q1 24 | $-912.8K | $-4.8M |
自由现金流AXILCTSO
| Q4 25 | $906.4K | $-4.9M | ||
| Q3 25 | $-747.6K | $-2.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | $-258.2K | $-3.5M | ||
| Q4 24 | $941.1K | $-2.4M | ||
| Q3 24 | — | $-2.6M | ||
| Q2 24 | $-394.9K | $-4.8M | ||
| Q1 24 | $-922.1K | $-4.9M |
自由现金流率AXILCTSO
| Q4 25 | 11.1% | -53.4% | ||
| Q3 25 | -10.9% | -27.3% | ||
| Q2 25 | — | -16.1% | ||
| Q1 25 | -3.7% | -39.7% | ||
| Q4 24 | 12.2% | -26.3% | ||
| Q3 24 | — | -30.4% | ||
| Q2 24 | -6.1% | -54.4% | ||
| Q1 24 | -14.3% | -54.2% |
资本支出强度AXILCTSO
| Q4 25 | 0.3% | 1.2% | ||
| Q3 25 | 0.1% | 0.2% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | 1.3% | 0.0% | ||
| Q4 24 | 0.9% | 0.8% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | 0.9% | 0.2% | ||
| Q1 24 | 0.1% | 0.5% |
现金转化率AXILCTSO
| Q4 25 | 1.33× | — | ||
| Q3 25 | -2.21× | — | ||
| Q2 25 | — | -0.78× | ||
| Q1 25 | -0.29× | — | ||
| Q4 24 | 1.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6.80× | — | ||
| Q1 24 | -1.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXIL
| Hearing Enhancement And Protection | $7.8M | 95% |
| Other | $378.9K | 5% |
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
